David Giddings - Chief Executive Officer
Mr. Giddings has a rich career focused on information technology and biotechnology businesses with both established and emerging publicly and privately held companies. Most recently, he served as President and CEO of Digilab INC, a global life science research tools company.
Mr Giddings’ previous positions include serving as Chairman, President, and CEO of Diametrics Medical, Inc. He joined Boehringer Mannheim Corporation as VP and General Manager of their Diagnostics Systems Division, and subsequently became President and COO of their U.S. In-Vitro Diagnostics operations. Mr. Giddings began his career with the Eastman Kodak Company, and held various general management and corporate executive positions including VP and General Manager of Kodak Clinical Diagnostics, VP and General Manager of Printing and Publishing, and VP and General Manager of Imaging and Information Systems.
Mr. Giddings has served on boards including ACCPAC, Gentra Systems Inc., recently sold to Qiagen, and Heartsine Inc. Currently, Mr. Giddings serves on the board of Liposcience supporting their technology sourcing and product development needs for advanced cardiovascular testing and molecular medicine services and products. Additionally, Mr. Giddings is a Director of Allotrope Pharmaceuticals and also serves as their CEO.
Mr. Giddings is a graduate of the Harvard Advanced Management Program, received his MBA from Rider University, and received his BA from Middlebury College.
Charles Haywood - Director of Corporate Strategy
Mr. Haywood has extensive experience in starting and growing manufacturing companies, as well as wide experience in regulatory and legal structures. He currently serves as the President and CEO of Mansfield-King, a contract manufacturer of personal care products. Mr. Haywood founded Mansfield-King in 2005. Mansfield-King was recognized in June 2010 by the Indiana Business Journal as the fifth fastest-growing business in Indiana over the past three years. The company also expects that in August 2010 it will also be recognized by Inc. magazine as the fastest growing personal care contract manufacturer in the country and the fastest growing business in Indiana over the past four years. Mansfield-King is regulated by the United States Food and Drug Administration and in that capacity Mr. Haywood has worked extensively with FDA regulations and their application.
Mr. Haywood is currently overseeing the further expansion of Mansfield-King through the creation of three spin-off businesses that expand Mansfield-King’s sale and capabilities while operating as separate corporate entities and profit centers. Before founding Mansfield-King, Mr. Haywood started, operated and sold a manufacturer of high-end cabinetry.
Mr. Haywood currently serves as Assistant Clinical Professor of Business Law at the Krannert School of Management at Purdue University. In that capacity he instructs students in basic business law, entrepreneurship, and ethics. In addition, Mr. Haywood serves as an informal advisor to a variety of entrepreneurial and established ventures.
Prior to his business experience, Mr. Haywood worked as Senior Counsel (equivalent to non-equity partner) at the law firm of Foley & Lardner in Chicago. Mr. Haywood worked at Foley & Lardner from 1995 to 2001 and specialized in private equity transactions, mergers/acquisitions, and securities offerings. From 1994 to 1995, Mr. Haywood also served as a Judicial Law Clerk to the Hon. Michael S. Kanne, on the United States Court of Appeals for the Seventh Circuit.
Mr. Haywood received an MBA, with high honors, from the University of Chicago; a Juris Doctorate from the University of Chicago; and a Bachelor of Arts from Indiana University
Rush Bartlett - Chief Operating Officer, Founder
Rush Bartlett received his B.S. in Chemical Engineering from the University of Texas at Austin. At the University of Texas, Rush was a researcher with Dr. Kenneth Diller, PhD, Chairman of Biomedical Engineering, in areas dealing with heat shock protein expression kinetics and cryopreservation preconditioning and was a member of the Longhorn Marching Band where he performed at the Rose Bowl, National Championship, and a Presidential Inauguration. Prior to Cofounding LyoGo Rush previously worked for General Electric and for Sabic Innovative Plastics in High Performance Polymers. Recently Rush earned his MBA from the Kelly School of Business at Indiana University while also finishing a PhD in Biomedical Engineering at Purdue University with Dr. Alyssa Panitch in the area of peptide and nucleic acid responsive drug-polymer nanosystems. Rush’s passion for innovation lies with the delivery of biomolecules for nanomedicine as well as the realization of innovatively simplistic high impact medical devices.
Peter Greco - Chief Business Development Officer, Founder
Mr. Greco is a consultant for the Battelle Memorial Institute in Columbus, Ohio. There, he supports the Health and Life Sciences business unit in their Engineered Drug Delivery Initiative. Peter received his MBA from Purdue University’s Krannert School of Management where he was Vice President of the student government. He concentrated on entrepreneurship, and corporate strategy. He graduated with a B.S. in Management from Purdue University with a focus on marketing. Upon completing his undergraduate studies, Mr. Greco worked in sales at the Global Sales Center for GE Supply in Indianapolis, IN. Peter has a passion for business development, and project management with a focus on the life sciences and technology. He worked for the marketing department at Roche Diagnostics in the Diabetes Care Division. During this time, Mr. Greco gained sales experience in the field calling on doctors, pharmacies and health insurance companies. Other experience includes being a participant in the inaugural 10X Accelerator, a summer long start-up business incubation program run by Ohio State University.
Art Chlebowski - Chief Technology Officer, Founder
Art Chlebowski received his BSBME, MSBME and is completing his PhD degree in the Weldon School of Biomedical Engineering at Purdue University. Over the course of both degrees, he has worked in the fields of glaucoma, epilepsy, and cardiac implantable devices focusing on the development and manufacturing of packaging for these devices. While researching, several US patents have been submitted, and work is being done to begin clinical trials on such devices. Starting in the summer of 2009 Art’s PhD work will focusing on implantable wirelessly powered medical devices along with his responsibilities at LyoGo. What he would like to accomplish in the future is to become a translational researcher, by taking the techniques and devices he designed and learned from his research experiences, and translate the ideas into functional industrial tools to be used in medical devices that have a propensity for high personal impact for others lives.